The ERA Chairs project RareBoost will greatly facilitate the development of IBG’s rare diseases focus towards an international level of excellence in research and innovation.
IBG has already taken significant steps, nationally and internationally, towards research and innovation excellence in rare diseases.
RareBoost’s team involves several of IBG’s principle investigators and several rare disease experts.
We are searching for a senior scientist with a strong background in rare disease research to join us as ERA Chair holder. If you think you could be this person, please review the requirements and the selection procedure here.
IBG’s infrastructure is exceptional in Turkey in regard to quality, size and its unique composition. Furthermore, IBG has a strong and multidisciplinary faculty, and such a multidisciplinary, collaborative approach is considered optimal to address complex scientific questions like rare diseases. Major challenges in the field include ill-defined technical standards for disease data acquisition and sharing, limits in databases to correlate phenotypes with genomic variations and a scarcity of in vitro and in vivo models to study the underlying mechanism.
These challenges will be addressed by RareBoost.